November 18, 2026
Health news, explained with evidence
LIVE

Scientists Discover Genetic 'Dimmer Switch' That May Help Control Severe Sepsis

🧠 AI Analysis 2 min read 👁 4

Researchers at the University of California, Santa Cruz, have identified an RNA molecule that acts as a genetic rheostat, controlling inflammation and metabolism during severe immune responses.

Scientists Discover Genetic 'Dimmer Switch' That May Help Control Severe Sepsis🧠AI Analysis

Photo: Medical Xpress

Key points

  • Gaplinc acts as a long noncoding RNA that regulates immune response and metabolism.
  • Mouse models lacking Gaplinc showed 100 percent survival against lethal bacterial toxins.
  • The discovery may lead to future RNA-based therapeutics for critical care.

A research team at the University of California, Santa Cruz, has uncovered a molecular mechanism that influences survival during life-threatening inflammation. Published in the Proceedings of the National Academy of Sciences, the study centers on a specific long noncoding RNA molecule named Gaplinc, which acts as a genetic dimmer switch to regulate both cellular metabolism and inflammatory activity within immune cells.

Sepsis arises when the body mounts an extreme overreaction to an infection, setting off runaway inflammation that can lead to organ failure. According to data cited from the Centers for Disease Control and Prevention, the condition claims the lives of at least 20 percent of adults and 10 percent of children who develop it, appearing in roughly one-third of all US hospital deaths. Current medical interventions remain largely limited to supportive care, fluids, and antibiotics, as clinicians lack targeted drugs to halt the destructive inflammatory cascade.

In animal models, investigators found that removing Gaplinc altered blood fats into a protective, sepsis-resistant state, enabling all of the deficient subjects to survive lethal toxin levels that killed normal subjects. Conversely, overproduction of Gaplinc left subjects more vulnerable to rapid, fatal shock. The authors suggest that temporary RNA therapeutics, such as lipid nanoparticles, could potentially be used to adjust Gaplinc levels during an acute infection.

What to know: While the discovery points to a promising new strategy for drug development, the findings currently derive from animal models and early-stage laboratory research. Readers should consult a qualified healthcare provider for any personal medical decisions or health concerns.

Source Medical Xpress — medicalxpress.com/news/2026-11-genetic-dimmer-boost-sepsis-resistance.h… ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.